Compounds, organized by research domain.
Every compound page includes molecular identity, mechanism under investigation, evidence map, current lot information, and primary-source references. Purchasing requires researcher verification.
Hypothalamic & Pituitary
Hypothalamic & Pituitary Signaling
- LyophilizedEvidence III
CJC-1295 (No DAC)
GHRH analogue / identity pendingCJC-1295 is a growth-hormone-releasing-hormone analogue developed to extend GHRH activity. Products sold as “CJC-1295 without DAC” are often chemically different from true CJC-1295 and may instead be modified GRF(1-29), making exact sequence verification essential.
10 mgView profile - LyophilizedEvidence I
hCG
Glycoprotein hormoneHuman chorionic gonadotropin is a heterodimeric glycoprotein hormone that activates the luteinizing-hormone/chorionic-gonadotropin receptor. It is extensively studied in reproductive endocrinology and gonadal steroidogenesis.
10,000 IUView profile - LyophilizedEvidence I
hMG
Gonadotropin preparationHuman menopausal gonadotropin preparations contain follicle-stimulating and luteinizing hormone activity and are studied and used in reproductive endocrinology.
75 IUView profile - LyophilizedEvidence III
IGF-1 LR3
IGF-1 analogueIGF-1 LR3 is a modified insulin-like growth factor analogue used in experimental research on growth signaling, glucose metabolism, protein synthesis, cell survival, and proliferation.
1 mgView profile - LyophilizedEvidence III
Ipamorelin
Ghrelin-receptor agonistIpamorelin is a synthetic pentapeptide studied for selective stimulation of growth-hormone release through the ghrelin receptor.
10 mgView profile - LyophilizedEvidence II
Kisspeptin
Reproductive neuropeptideKisspeptin peptides are endogenous regulators of reproductive neuroendocrine signaling and are studied in puberty, fertility, hypothalamic function, and gonadotropin release.
10 mgView profile - LyophilizedEvidence II
Sermorelin
GHRH(1-29) analogueSermorelin is a synthetic analogue of the biologically active N-terminal portion of growth-hormone-releasing hormone and is used in research on pituitary GH secretion and endocrine testing.
5 mg · 15 mgView profile - LyophilizedEvidence I
Tesamorelin
Stabilized GHRH analogueTesamorelin is a synthetic growth-hormone-releasing-factor analogue studied in pituitary GH release, IGF-1 signaling, body-composition research, and metabolic effects.
5 mg · 10 mgView profile
Cellular & Matrix
Cellular Response & Matrix Biology
- LyophilizedEvidence IV
BPC-157
Synthetic pentadecapeptideBPC-157 is a 15-amino-acid synthetic peptide studied in laboratory and animal models involving angiogenesis, nitric-oxide signaling, fibroblast activity, and extracellular-matrix response pathways.
5 mg · 10 mgView profile - LyophilizedEvidence III
GHK-Cu
Copper-binding tripeptideGHK-Cu is a naturally occurring copper-binding tripeptide complex studied in extracellular-matrix biology, wound models, gene-expression research, skin biology, inflammation, and tissue remodeling.
50 mg · 100 mgView profile - LyophilizedEvidence IV
SNAP-8
Synthetic octapeptideSNAP-8, commonly identified as acetyl octapeptide-3, is studied primarily in topical cosmetic and cellular models involving SNARE-complex-related neurotransmitter release and expression-line appearance.
10 mgView profile - LyophilizedEvidence IV
TB-500
Thymosin beta-4-related material“TB-500” is a marketplace term often associated with thymosin beta-4 or a related fragment. Exact sequence and molecular identity must be confirmed before scientific literature can be assigned to the product.
5 mg · 10 mgView profile
Senescence & Mitochondrial
Cellular Senescence & Mitochondrial Signaling
- LyophilizedEvidence III
Epitalon
Synthetic tetrapeptideEpitalon, also spelled epithalon, is a synthetic tetrapeptide associated with research on pineal biology, circadian signaling, cellular aging, telomere-related hypotheses, and oxidative stress.
25 mgView profile - LyophilizedEvidence V
FOXO4-DRI
Experimental FOXO4–p53 interaction research peptideFOXO4-DRI is an experimental cell-penetrating peptide investigated in preclinical models involving the FOXO4–p53 interaction and cellular senescence. Published evidence remains limited primarily to cellular and animal models, and no established human safety or efficacy profile exists.
10 mgView profile - LyophilizedEvidence IV
MOTS-c
Mitochondrial-derived peptideMOTS-c is a peptide encoded within mitochondrial 12S rRNA and studied in cellular stress responses, glucose metabolism, AMPK signaling, exercise biology, aging, and mitochondrial–nuclear communication.
10 mg · 20 mgView profile
Receptor & Metabolic
Receptor Pharmacology & Metabolic Signaling
- LyophilizedEvidence II
Cagrilintide
Amylin analogueCagrilintide is an investigational, long-acting analogue of the pancreatic hormone amylin. Research has focused on appetite regulation, gastric emptying, energy intake, and its use in combination with incretin-based agents.
10 mgView profile - LyophilizedEvidence I
Semaglutide
GLP-1 receptor agonistSemaglutide is a modified peptide analogue of human glucagon-like peptide-1 with an extensive published literature in GLP-1 receptor pharmacology and downstream metabolic signaling.
3 mg · 6 mg · 10 mgView profile - LyophilizedEvidence I
Tirzepatide
Dual incretin agonistTirzepatide is a synthetic peptide investigated for coordinated activation of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptors in receptor-pharmacology and metabolic-signaling research.
10 mg · 20 mg · 30 mgView profile - LyophilizedEvidence II
Retatrutide
Triple receptor agonistRetatrutide is an investigational peptide engineered to activate GIP, GLP-1, and glucagon receptors; investigational research is examining coordinated incretin and glucagon-receptor pharmacology.
16 mg · 30 mgView profile - LyophilizedEvidence IV
5-Amino-1MQ
Small-molecule NNMT inhibitor5-Amino-1MQ is a synthetic small molecule used in experimental research involving nicotinamide N-methyltransferase, cellular methyl-donor metabolism, adipocyte biology, and metabolic regulation.
50 mgView profile - LyophilizedEvidence III
AOD-9604
Growth-hormone fragmentAOD-9604 is a modified peptide derived from the C-terminal region of human growth hormone. It has been investigated in metabolic and adipose-tissue research, including earlier clinical development programs.
5 mg · 10 mgView profile - ReconstitutedEvidence N/A
Lipo-C
Undefined mixtureLipo-C is a commercial naming convention rather than a defined scientific substance. Content may include combinations of amino acids, choline-related compounds, B vitamins, or other ingredients.
1050 mgView profile - ReconstitutedEvidence I
L-Carnitine
Quaternary ammonium metaboliteL-carnitine is an endogenous metabolite required for transport of long-chain fatty acids into mitochondria and is widely studied in energy metabolism and carnitine-deficiency states.
5,000 mgView profile - CapsuleEvidence V
SLU-PP-332
Experimental small moleculeSLU-PP-332 is an experimental small molecule studied as an estrogen-related receptor agonist in models of oxidative metabolism, mitochondrial function, exercise adaptation, and energy expenditure.
250 mcg × 100View profile
Immune & Cytokine
Immune & Cytokine Signaling
- LyophilizedEvidence IV
LL-37
Human cathelicidin peptideLL-37 is an endogenous antimicrobial peptide studied in innate immunity, membrane disruption, chemotaxis, biofilm biology, inflammation, wound models, and host-defense signaling.
5 mgView profile - LyophilizedEvidence III
Thymalin
Thymic peptide preparationThymalin is described in historical literature as a thymus-derived peptide preparation studied in immune and aging-related contexts. It may represent a mixture rather than a single chemically defined peptide.
25 mgView profile - LyophilizedEvidence II
Thymosin Alpha-1
Thymic peptideThymosin alpha-1 is a 28-amino-acid peptide studied in innate and adaptive immune signaling, T-cell function, dendritic-cell activity, infection, oncology adjunct research, and immune dysregulation.
5 mg · 10 mgView profile
Neuropeptide Signaling
Experimental Neuropeptide Signaling
- LyophilizedEvidence IV
DSIP
Delta sleep-inducing peptideDelta sleep-inducing peptide is a short neuropeptide historically investigated in sleep, stress-response, neuroendocrine, pain, and withdrawal models.
5 mgView profile - LyophilizedEvidence III
Selank
Synthetic heptapeptideSelank is a synthetic peptide derived from a tuftsin fragment and studied in neurobehavioral, stress-response, immune, and gene-expression models.
10 mgView profile - LyophilizedEvidence III
Semax
Synthetic ACTH-derived peptideSemax is a synthetic peptide based on an ACTH fragment and studied in neuroprotection, cognition, ischemia models, neurotrophic signaling, and stress response.
10 mgView profile
Neuroendocrine Receptor
Neuroendocrine Receptor Signaling
- LyophilizedEvidence III
Melanotan II
Melanocortin analogueMelanotan II is a synthetic cyclic melanocortin analogue studied in pigmentation, melanocortin receptor pharmacology, appetite, autonomic responses, and sexual-function pathways.
10 mgView profile - LyophilizedEvidence I
Oxytocin
Endogenous nonapeptide hormoneOxytocin is an endogenous nonapeptide studied in uterine contractility, lactation, social and behavioral neuroscience, autonomic signaling, and reproductive physiology.
10 mgView profile - LyophilizedEvidence I
PT-141 / Bremelanotide
Melanocortin receptor agonistBremelanotide is a cyclic melanocortin receptor agonist investigated in sexual-function and central melanocortin signaling research.
10 mgView profile
Redox & Cofactor
Redox & Cofactor Biology
- LyophilizedEvidence II
Glutathione
Endogenous tripeptideGlutathione is an endogenous tripeptide central to cellular redox balance, electrophile detoxification, peroxide metabolism, and maintenance of protein thiol status.
1500 mgView profile - LyophilizedEvidence II
NAD+
Oxidized nicotinamide adenine dinucleotideNAD+ is an essential cellular redox cofactor and substrate for enzymes including sirtuins, PARPs, and cyclic ADP-ribose synthases. Research spans energy metabolism, DNA repair, stress signaling, and aging biology.
500 mg · 1000 mgView profile
Multi-Component Materials
Multi-Component Research Materials
- LyophilizedEvidence V
GLOW Blend
BPC-157 / TB-500-labeled / GHK-Cu blendThe GLOW blend combines BPC-157, a TB-500-labeled thymosin-beta-4-related material, and GHK-Cu. Each constituent has a distinct evidence base, and the combined formulation itself may have little or no published validation.
70 mg (10/10/50)View profile - LyophilizedEvidence V
KLOW Blend
BPC-157 / TB-500-labeled / GHK-Cu / KPV blendThe KLOW blend combines BPC-157, TB-500-labeled material, GHK-Cu, and KPV. The mixture spans several experimental pathways, but the combined product itself lacks an established research or safety profile.
70 mg (10/10/10/50)View profile - LyophilizedEvidence V
AOD-9604 / CJC-1295 / Ipamorelin
Three-component blendThis blend combines AOD-9604 with two growth-hormone-axis research peptides. The mixture itself has no established evidence base and must be evaluated separately from its constituents.
12 mg (6/3/3)View profile - LyophilizedEvidence V
BPC-157 / TB-500 Blend
Two-component blendThis blend combines BPC-157 with a TB-500-labeled thymosin-beta-4-related material. Published research generally evaluates the components separately rather than the mixture.
10 mg · 20 mgView profile - LyophilizedEvidence V
CJC-1295 / Ipamorelin Blend
Two-component endocrine blendThis blend combines a GHRH-receptor agonist material with a ghrelin-receptor agonist. The commercial combination itself has limited formal research.
10 mgView profile - LyophilizedEvidence V
Tesamorelin / CJC-1295 / Ipamorelin
Three-component endocrine blendThis blend combines two GHRH-pathway materials with a ghrelin-receptor agonist. There is no established scientific rationale for assuming that combining overlapping secretagogues improves reproducibility or safety.
12 mg (6/3/3)View profile
Alternate Formats
Alternate Research Formats
- CapsuleEvidence IV
BPC-157 Capsules
Oral research formatOral capsule presentation of BPC-157. Bioavailability, stability, and regulatory classification of capsule formats are unresolved.
500 mcg × 60 · 1000 mcg × 60View profile - CapsuleEvidence III
GHK-Cu Capsules
Oral research formatOral capsule format containing GHK-Cu. Route-specific stability and bioavailability require direct evidence.
3 mg × 60View profile